Pfizer and Lilly lead a parade of U.S. companies that have paid $7 billion in penalties after promoting drugs for uses not approved by the FDA, according to a report by David Evans for the December issue of Bloomberg Markets. This unlawful behavior may not end until prosecutors force a drug company into bankruptcy.
Looks like you haven't made a choice yet.
